Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.080
+0.050 (1.65%)
May 16, 2025, 4:00 PM - Market closed
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $390.71 million as of May 19, 2025. Its market cap has increased by 17.97% in one year.
Market Cap
390.71M
Enterprise Value
323.38M
1-Year Change
17.97%
Ranking
Category
Stock Price
$3.08
Market Cap Chart
Since January 5, 2017, Organogenesis Holdings's market cap has increased from $376.60M to $390.71M, an increase of 3.75%. That is a compound annual growth rate of 0.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 390.70M | -7.90% |
| Dec 31, 2024 | 424.20M | -21.44% |
| Dec 29, 2023 | 540.00M | 53.32% |
| Dec 30, 2022 | 352.20M | -70.37% |
| Dec 31, 2021 | 1.19B | 46.45% |
| Dec 31, 2020 | 811.60M | 78.10% |
| Dec 31, 2019 | 455.70M | 30.13% |
| Dec 31, 2018 | 350.20M | -8.90% |
| Dec 29, 2017 | 384.40M | 2.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |